Stoke Therapeutics

0 followers

‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Biotechnology

Headquarters

Bedford, United States

Employees

51-200

Links

Org chart

Edward M. Kaye

CEO & Director

Edward M. Kaye

Collapse

Stephen J. Tulipano

CFO

Dawn Kalmar

Chief Communications Officer

Barry S. Ticho

Chief Medical Officer

Shamim Ruff

Chief Regulatory Officer

Huw M. Nash

Chief Operating & Business Officer

Jonathan Allan

General Counsel

Isabel Aznarez

Co-Founder & VP, Discovery Research

Meena

VP, Bioanalytical, DMPK & Biomarker Development

Christy Chaves Blaney

Senior Director, Head Of Talent Acquisition

James Stutely

Head, Clinical Data Management

Kimberly Parkerson

Senior Vice President, Head Of Neurology Clinical Development

Lorene Kush

Executive Assistant To Chief Executive Officer

Malini Viswanathan Ph.D

Vice President Portfolio and Alliance Management

Parisa S.

Executive Director, Patient Advocacy, Policy, And Stakeholder Engagement

Samuel Manoranjan

Vice President of Quality

Stephen Yu

VP Head of IT

Jason Hoitt

Chief Commercial Officer (cco)

Teams

+27

Research and Development

30 members

Clinical Operations

12 members

Leadership Team

9 members

Clinical Operations

5 members

Operations and Compliance

6 members

Research and Development

5 members

Similar companies

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Quantum-Si

2 followers

Jnana Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

Cytokinetics

11 followers

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

Lighthouse Worldwide Solutions

1 follower

Axsome Therapeutics

2 followers

BridgeBio

2 followers

Explore companies